The Cancer Prognostics and Health Outcomes Unit of the University of Montreal, directed by Dr. Pierre Karakiewicz, in collaboration with several centers of excellence from around the world has developed a series of computerized devices to help patients and their physicians decide among the major treatment choices for several cancers and non-malignant conditions. The available applications, developed by Pierre Karakiewicz et al., can be used in prostate, bladder and kidney cancers, as well as in renal transplantation.